Big Health Receives FDA Clearance for DaylightRx
First non-drug FDA-cleared treatment for generalized anxiety disorder (GAD).
Big Health, a leading name in digital mental health solutions, has achieved a significant milestone by obtaining clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking digital therapeutic, DaylightRx. This approval is particularly noteworthy as DaylightRx is now the first FDA-approved digital treatment specifically designed for generalized anxiety disorder (GAD). The next step involves making this innovative therapeutic available through licensed healthcare providers who can prescribe it to those who qualify.
What is DaylightRx and Why Does It Matter?
DaylightRx employs evidence-based methods derived from cognitive behavioral therapy (CBT) specifically tailored for individuals experiencing GAD. The goal of this therapeutic is to help alleviate chronic worry and anxiety by equipping users with practical strategies. The treatment consists of interactive lessons that cover various techniques, such as applied relaxation, stimulus control to reduce the frequency of worries, cognitive restructuring to challenge anxious thoughts, and exposure exercises to lessen the intensity of worry.
This structured approach includes guided practice sessions over a 90-day treatment period. Participants in DaylightRx will have the opportunity to incorporate these strategies into their daily lives, potentially leading to improved mental well-being.
The Effects of Generalized Anxiety Disorder
Generalized anxiety disorder is characterized by excessive, uncontrollable worry, often accompanied by various physical symptoms that can disrupt daily activities. GAD is one of the most common anxiety disorders, imposing a staggering economic burden of over $53 billion annually on the U.S. economy. Additionally, individuals with GAD face a higher risk of developing other health issues, including depression, diabetes, heart disease, and hypertension.
DaylightRx's Proven Effectiveness
Clinical trials have highlighted the effectiveness of DaylightRx, revealing a remarkable remission rate of over 70%. Many patients have reported significant reductions in anxiety levels, which are often sustained for six months or longer after completing the treatment. These encouraging results offer hope to those grappling with this chronic condition.
Recent Progress and Future Plans
This clearance represents the second FDA-approved product from Big Health within a single year, following the earlier authorization of their SleepioRx treatment for insomnia disorder. Additionally, upcoming changes in healthcare reimbursements, including proposals for the 2025 Medicare Physician Fee Schedule, may pave the way for coverage of FDA-cleared digital mental health therapies like DaylightRx and SleepioRx.
By incorporating these digital therapeutic solutions into clinical practice, Big Health aims to improve access to mental health care for individuals nationwide, addressing the urgent need for effective treatment options.
A Message from Big Health's Leadership
Yael Berman, CEO of Big Health, emphasized the company's commitment to expanding non-pharmaceutical treatment options for anxiety. "For too long, patients seeking non-drug alternatives have had limited choices. With our FDA-cleared treatment, we are excited to provide an effective option that patients can rely on, boasting impressive remission rates of over 70%." This commitment highlights Big Health's mission to deliver accessible mental health care solutions to those in need.
About Big Health
Big Health is devoted to enhancing mental health on a large scale by developing digital treatments for common conditions such as insomnia, anxiety, and depression. With more than 90 research publications and 18 rigorous clinical trials to their name, their programs are crafted by leading experts in the field. For over a decade, Big Health has partnered with employers, health plans, and global health systems to provide scalable mental health care solutions. To explore more about Big Health's offerings, visit their website.
Frequently Asked Questions
What is DaylightRx?
DaylightRx is an FDA-cleared digital therapeutic designed to treat generalized anxiety disorder using cognitive behavioral therapy techniques.
How does DaylightRx work?
This treatment provides interactive lessons and exercises that focus on techniques to reduce anxiety and improve mental well-being.
What are the benefits of using DaylightRx?
DaylightRx has shown a remission rate of over 70% in clinical trials, significantly reducing anxiety levels for many users.
Who can use DaylightRx?
DaylightRx is intended for patients aged 22 years and older who are struggling with symptoms of generalized anxiety disorder.
What other treatments does Big Health offer?
In addition to DaylightRx, Big Health provides various digital solutions for insomnia, anxiety, and depression, focusing on accessible mental health care.
